Telix Pharmaceuticals Limited
General ticker "TLPPF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.1B (TTM average)
Telix Pharmaceuticals Limited follows the US Stock Market performance with the rate: 40.5%.
Estimated limits based on current volatility of 1.6%: low 8.66$, high 8.97$
Factors to consider:
- Total employees count: 1120 (+109.3%) as of 2025
Short-term TLPPF quotes
Long-term TLPPF plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | AUD783.21MM | AUD816.40MM |
| Operating Expenses | AUD701.08MM | AUD798.35MM |
| Operating Income | AUD82.13MM | AUD18.04MM |
| Non-Operating Income | AUD-26.07MM | AUD-23.39MM |
| Interest Expense | AUD21.46MM | AUD37.29MM |
| R&D Expense | AUD121.03MM | AUD173.93MM |
| Income(Loss) | AUD56.06MM | AUD-5.35MM |
| Taxes | AUD6.14MM | AUD1.89MM |
| Net Income(Loss)* | AUD68.95MM | AUD-7.24MM |
| Stockholders Equity | AUD568.21MM | AUD415.49MM |
| Inventory | AUD38.14MM | AUD37.09MM |
| Assets | AUD1,516.43MM | AUD1,182.44MM |
| Operating Cash Flow | AUD43.03MM | AUD-17.56MM |
| Capital expenditure | AUD34.03MM | AUD38.51MM |
| Investing Cash Flow | AUD-135.17MM | AUD-290.40MM |
| Financing Cash Flow | AUD638.92MM | AUD-3.78MM |
| Earnings Per Share** | AUD0.21 | AUD-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.